Chronic joint pain 3 years after chikungunya virus infection largely characterized by relapsing-remitting symptoms

Objective. To determine the frequency of chronic joint pain and stiffness 3 years after infection with chikungunya virus in a Latin American cohort. Methods. A cross-sectional follow-up of 120 patients from an initial cohort of 500 patients who reported joint pain 2 years after infection from the At...

Full description

Autores:
Tritsch, Sarah R.
Encinales, Liliana
Pacheco, Nelly
Cadena, Andres
Cure, Carlos
McMahon, Elizabeth
Watson, Hugh
Porras Ramirez, Alexandra
Rico Mendoza, Alejandro
Li, Guangzhao
Khurana, Kunal
Jaller-Radd, Juan Jose
Mejia Castillo, Stella
Barrios Taborda, Onaldo
Jaller Char, Alejandro
Jaller-Char, Juan Jose
Avendaño Echavez, Lil
Jiménez, Dennys
Gonzalez Coba, Andres
Alarcon Gomez, Magda
Ariza Orozco, Dores
Bravo, Eyda
Martinez, Victor
Guerra, Brenda
Simon, Gary
Firestein, Gary S.
Chang, Aileen Y.
Tipo de recurso:
Fecha de publicación:
2019
Institución:
Universidad Simón Bolívar
Repositorio:
Repositorio Digital USB
Idioma:
eng
OAI Identifier:
oai:bonga.unisimon.edu.co:20.500.12442/4460
Acceso en línea:
https://hdl.handle.net/20.500.12442/4460
Palabra clave:
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Description
Summary:Objective. To determine the frequency of chronic joint pain and stiffness 3 years after infection with chikungunya virus in a Latin American cohort. Methods. A cross-sectional follow-up of 120 patients from an initial cohort of 500 patients who reported joint pain 2 years after infection from the Atlántico Department, Colombia. Patients were clinically diagnosed as having chikungunya virus during the 2014–2015 epidemic, and baseline and follow-up symptoms at 40 months were evaluated in serologically confirmed cases. Results. Of the initial 500 patients enrolled in the study, 482 had serologically confirmed chikungunya infection. From this group, 123 patients reported joint pain 20 months after infection, and 54% of those patients reported continued joint pain 40 months after infection. Therefore, 1 out of every 8 people who tested serologically positive for chikungunya infection had persistent joint pain 3 years after infection. Participants that followed up in-person were predominantly adult (mean ± SD age 51 ± 14 years) and female (86%). The most common type of pain reported in these patients at 40 months post-infection was pain with periods of relief and subsequent reoccurrence, and over 75% reported stiffness after immobility, with 39% experiencing morning stiffness. Conclusion. This is the first report to describe persistent joint pain and stiffness 40 months after viral infection. The high frequency of chronic disease highlights the need to develop prevention and treatment methods. Further studies should be conducted to understand the similarities between post-chikungunya joint pain and rheumatoid arthritis.